Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by HippygirL74on May 02, 2008 6:19pm
217 Views
Post# 15033388

RE: I agree

RE: I agree
rbmlong, you said,

"It's the same old crap....promise but don't deliver. Cardiac partner was to be signed in first quarter. Still waiting on FDA approval for Nt test. No new tests in the pipeline. They need to drop the FDA tests, they're taking way too long and go for veterinary market or home testing."
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
well, that's just not true, rbmlong.  If you drop the FDA tests then the barrier to entry is gone.  You need a very high barrier to entry to gain the advantage.  i am patient with the FDA, they are being extremely careful these days for everyone.  My guess is that the cardiac partner is sitting in the background and will be announced with, or soon after nt-proBNP FDA approval announced.  The FDA is slow for everyone, even for RBM's competitors. 

imo, as we get closer to the autumn, the shareprice will rise based on the anticipation of the 3M Launch to the 2008/2009 flu season.   And if we get ntproBNP approval and the cardiac partner, that will be a triple threat!

It wouldn't surprise me if some other company is considering a takeover of RBM. 

As for the current shareprice, who knows, manipulation can occur.  Who cares, let them sell- that's what makes a market.  Either the sellers don't think that the latest positive news will contribute to the bottom line, or there is an attempt to manipulate- just speculating.  But i am in for the whole business cycle to complete now- that is the business plan established by the new BOD.  And they must be confident despite the obligatory warnings, otherwise why would they have signed a 15 year lease at the new premises.  Am I right?

Insiders were buying?  That was a "Hurting20" requirement.  It wouldn't surprise me if he is the owner of those 1,000,000 shares crossed the other day.  Since he is not saying anything, he is probably accumulating!  Like lpdf, he can't be far! 

Once, d2drw, said that the manufacturing of the test cartridges were really "cheesy" or some term like that.  He had a good point too.  An employee was putting the paper into the plastic housing and pressing it all together with a vice grip.  Well, that has changed too with automated machines.  And the RAMP200 answers some of his other concerns. 

So, you see, we had some very useful debates over the years.

Holding long for the final stretch now.  Good luck to all.

ps. Hi to Advaita.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse